{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:40:26Z","timestamp":1794454826167,"version":"4.9.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.tranon.2023.101710","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T21:03:52Z","timestamp":1686863032000},"page":"101710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Low-dose radiotherapy effects the progression of anti-tumor response"],"prefix":"10.1016","volume":"35","author":[{"given":"Lei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0001","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-022-02264-x","article-title":"Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity","volume":"41","author":"Archilla-Ortega","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.tranon.2023.101710_bib0002","first-page":"358","article-title":"B cells and tumor immune escape. Zhong nan da xue xue bao Yi xue ban","volume":"47","author":"Li","year":"2022","journal-title":"J. Cent. South Univ. Med. Sci."},{"key":"10.1016\/j.tranon.2023.101710_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656364","article-title":"Aspects of the tumor microenvironment involved in immune resistance and drug resistance","volume":"12","author":"Khalaf","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2023.101710_bib0004","article-title":"Various uses of Pd1\/Pd-L1 inhibitor in oncology: opportunities and challenges","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0005","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3389\/fimmu.2018.02909","article-title":"Immunomodulation of the tumor microenvironment: turn foe into friend","volume":"9","author":"Locy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2023.101710_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783236","article-title":"Strategies to improve the antitumor effect of immunotherapy for hepatocellular carcinoma","volume":"12","author":"Xing","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.tranon.2023.101710_bib0007","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705361","article-title":"Immunogenic cell death induction by ionizing radiation","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2023.101710_bib0009","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3389\/fimmu.2020.01624","article-title":"Colorectal Cancer immunotherapy: options and strategies","volume":"11","author":"Johdi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2023.101710_bib0010","article-title":"Tumor immune microenvironment and immunotherapy in brain metastasis from non-small cell lung cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2023.101710_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106663","article-title":"Abscopal effect in radioimmunotherapy","volume":"85","author":"Ashrafizadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.tranon.2023.101710_bib0012","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/1878-0261.12658","article-title":"Radiotherapy-immunotherapy combinations - perspectives and challenges","volume":"14","author":"Mondini","year":"2020","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41368-020-00087-0","article-title":"Radiotherapy targeting cancer stem cells \"awakens\" them to induce tumour relapse and metastasis in oral cancer","volume":"12","author":"Liu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.tranon.2023.101710_bib0014","first-page":"1","article-title":"Minimizing second cancer risk following radiotherapy: current perspectives","volume":"7","author":"Ng","year":"2015","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.tranon.2023.101710_bib0015","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/HP.0000000000001033","article-title":"Linear No-threshold (Lnt) Vs. hormesis: paradigms, assumptions, and mathematical conventions that bias the conclusions in favor of Lnt and against hormesis","volume":"116","author":"Sacks","year":"2019","journal-title":"Health Phys."},{"issue":"3","key":"10.1016\/j.tranon.2023.101710_bib0016","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.canrad.2021.06.002","article-title":"Radiation dose to the low axilla in patients treated for early-stage breast cancer by locoregional intensity-modulated radiotherapy (Imrt)","volume":"26","author":"Abbassi","year":"2022","journal-title":"Cancer Radiother."},{"issue":"4","key":"10.1016\/j.tranon.2023.101710_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/0300060519892382","article-title":"A Retrospective cohort study of low-dose intensity-modulated radiotherapy for unresectable liver metastases","volume":"48","author":"Pei","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.tranon.2023.101710_bib0018","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fimmu.2019.00317","article-title":"Low-dose total body irradiation can enhance systemic immune related response induced by hypo-fractionated radiation","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2023.101710_bib0019","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fonc.2012.00120","article-title":"Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose X-irradiation","volume":"2","author":"R\u00f6del","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0020","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3389\/fonc.2019.01378","article-title":"A brief review of low-dose rate (Ldr) and high-dose rate (Hdr) brachytherapy boost for high-risk prostate","volume":"9","author":"Fischer-Valuck","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0167-8140(03)00247-0","article-title":"The potential palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemo-resistant non-hodgkin's lymphoma","volume":"69","author":"Safwat","year":"2003","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-1115-8_1","article-title":"A brief outline of the immune system","volume":"1184","author":"Tomar","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tranon.2023.101710_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tranon.2023.101710_bib0024","article-title":"Functional and therapeutic significance of tumor-associated macrophages in colorectal cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fimmu.2020.00784","article-title":"The tumor microenvironment in the response to immune checkpoint blockade therapies","volume":"11","author":"Petitprez","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2023.101710_bib0026","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","article-title":"Nk cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.tranon.2023.101710_bib0027","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.tranon.2023.101710_bib0028","first-page":"227","article-title":"Low-dose cancer risk modeling must recognize up-regulation of protection","volume":"8","author":"Feinendegen","year":"2009","journal-title":"Dose Response"},{"issue":"4","key":"10.1016\/j.tranon.2023.101710_bib0029","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12079-014-0250-x","article-title":"Radiation-hormesis phenotypes, the related mechanisms and implications for disease prevention and therapy","volume":"8","author":"Scott","year":"2014","journal-title":"J. Cell Commun. Signal."},{"issue":"5","key":"10.1016\/j.tranon.2023.101710_bib0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1586\/era.10.217","article-title":"Low-dose radiation therapy of cancer: role of immune enhancement","volume":"11","author":"Farooque","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"3","key":"10.1016\/j.tranon.2023.101710_bib0031","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1667\/RR3123","article-title":"Single Low doses of x rays inhibit the development of experimental tumor metastases and trigger the activities of nk cells in mice","volume":"161","author":"Cheda","year":"2004","journal-title":"Radiat. Res."},{"issue":"4","key":"10.1016\/j.tranon.2023.101710_bib0032","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2203\/dose-response.12-018.Nowosielska","article-title":"Effect of low doses of low-let radiation on the innate anti-tumor reactions in radioresistant and radiosensitive mice","volume":"10","author":"Nowosielska","year":"2012","journal-title":"Dose Response"},{"issue":"6","key":"10.1016\/j.tranon.2023.101710_bib0033","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jrr\/rrs037","article-title":"Augmentation of natural cytotoxicity by chronic low-dose ionizing radiation in murine natural killer cells primed by Il-2","volume":"53","author":"Sonn","year":"2012","journal-title":"J. Radiat. Res."},{"issue":"3","key":"10.1016\/j.tranon.2023.101710_bib0034","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of P38 mapk signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.tranon.2023.101710_bib0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by Jnk and P38 mapk pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.tranon.2023.101710_bib0036","first-page":"428","article-title":"Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapy","volume":"29","author":"Yang","year":"2014","journal-title":"Cancer Biother. Radiopharm."},{"issue":"5","key":"10.1016\/j.tranon.2023.101710_bib0037","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2023.101710_bib0038","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fonc.2020.00188","article-title":"Tumor-associated macrophages: recent insights and therapies","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.tranon.2023.101710_bib0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2023.101710_bib0041","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an inos\u207a\/m1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.tranon.2023.101710_bib0042","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/mc.22879","article-title":"Low dose radiation primed inos\u2009+\u2009M1macrophages modulate angiogenic programming of tumor derived endothelium","volume":"57","author":"Nadella","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.tranon.2023.101710_bib0043","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"Sting-dependent cytosolic dna sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.tranon.2023.101710_bib0044","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1269\/jrr.06048","article-title":"Effects of low-dose irradiation on enhancement of immunity by dendritic cells","volume":"48","author":"Shigematsu","year":"2007","journal-title":"J. Radiat. Res."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0046","doi-asserted-by":"crossref","DOI":"10.1177\/1559325819832144","article-title":"Exposure to low-dose radiation enhanced the antitumor effect of a dendritic cell vaccine","volume":"17","author":"Wang","year":"2019","journal-title":"Dose Response"},{"key":"10.1016\/j.tranon.2023.101710_bib0047","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.tranon.2023.101710_bib0048","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","article-title":"Cd4+ T cell help is required for the formation of a cytolytic Cd8+ T cell subset that protects against chronic infection and cancer","volume":"51","author":"Zander","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0049","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","article-title":"Metabolic regulation of T cell longevity and function in tumor immunotherapy","volume":"26","author":"Kishton","year":"2017","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.tranon.2023.101710_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2023.101710_bib0051","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2307\/3580211","article-title":"The Suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats","volume":"151","author":"Hashimoto","year":"1999","journal-title":"Radiat. Res."},{"issue":"7","key":"10.1016\/j.tranon.2023.101710_bib0052","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.4049\/jimmunol.1302736","article-title":"Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulation","volume":"192","author":"Spary","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0053","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.tranon.2023.101710_bib0054","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.trecan.2017.12.006","article-title":"B-cell metabolic remodeling and cancer","volume":"4","author":"Franchina","year":"2018","journal-title":"Trends Cancer"},{"issue":"51","key":"10.1016\/j.tranon.2023.101710_bib0055","doi-asserted-by":"crossref","first-page":"56874","DOI":"10.1021\/acsami.0c16548","article-title":"Radiosensitization effect of aguix, a gadolinium-based nanoparticle, in nonsmall cell lung cancer","volume":"12","author":"Du","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.tranon.2023.101710_bib0056","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ijrobp.2016.01.008","article-title":"Site-specific phosphorylation of ikaros induced by low-dose ionizing radiation regulates cell cycle progression of B lymphoblast through Ck2 and Akt activation","volume":"94","author":"Cho","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.tranon.2023.101710_bib0057","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.freeradbiomed.2011.06.014","article-title":"Induction of extracellular Atp mediates increase in intracellular thioredoxin in raw264.7 cells exposed to low-dose \u0393-rays","volume":"51","author":"Ohshima","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.tranon.2023.101710_bib0058","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/09553002.2017.1377362","article-title":"Identification of cellular responses to low-dose radiation by the profiling of phosphorylated proteins in human B-lymphoblast Im-9 Cells","volume":"93","author":"Eom","year":"2017","journal-title":"Int. J. Radiat. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0059","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/09553002.2010.518208","article-title":"Different radiosensitivity of Cd4(+)Cd25(+) regulatory T cells and effector T cells to low dose gamma irradiation in vitro","volume":"87","author":"Cao","year":"2011","journal-title":"Int. J. Radiat. Biol."},{"issue":"8","key":"10.1016\/j.tranon.2023.101710_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082391","article-title":"In vivo irradiation of mice induces activation of dendritic cells","volume":"19","author":"Persa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.tranon.2023.101710_bib0061","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1359-4117.2003.01093.x","article-title":"Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma","volume":"3","author":"Safwat","year":"2003","journal-title":"J. Exp. Ther. Oncol."},{"issue":"9","key":"10.1016\/j.tranon.2023.101710_bib0062","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ejca.2004.01.037","article-title":"Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2","volume":"40","author":"Safwat","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2023.101710_bib0063","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2203\/dose-response.07-020.Jin","article-title":"Whole-body low dose irradiation promotes the efficacy of conventional radiotherapy for cancer and possible mechanisms","volume":"5","author":"Jin","year":"2007","journal-title":"Dose Response"},{"issue":"3","key":"10.1016\/j.tranon.2023.101710_bib0064","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/09553000801902133","article-title":"Increase in efficacy of cancer radiotherapy by combination with whole-body low dose irradiation","volume":"84","author":"Wu","year":"2008","journal-title":"Int. J. Radiat. Biol."},{"issue":"7","key":"10.1016\/j.tranon.2023.101710_bib0065","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.7314\/APJCP.2013.14.7.4121","article-title":"Low-dose radiation induces antitumor effects and erythrocyte system hormesis","volume":"14","author":"Yu","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0066","doi-asserted-by":"crossref","DOI":"10.1177\/1559325817697531","article-title":"Treatment of cancer and inflammation with low-dose ionizing radiation: three case reports","volume":"15","author":"Kojima","year":"2017","journal-title":"Dose Response"},{"issue":"14","key":"10.1016\/j.tranon.2023.101710_bib0067","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147303","article-title":"Effects of chronic low-dose internal radiation on immune-stimulatory responses in mice","volume":"22","author":"Khan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2023.101710_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110026","article-title":"Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer","volume":"117","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tranon.2023.101710_bib0069","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2021.06.037","article-title":"High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: results of a phase Ii trial","volume":"162","author":"Patel","year":"2021","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2023.101710_bib0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2021.03.017","article-title":"Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma","volume":"161","author":"Sezen","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2017.01.004","article-title":"Radiotherapy for cancer: present and future","volume":"109","author":"Allen","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tranon.2023.101710_bib0072","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-444-52138-5.00016-5","article-title":"Radiotherapy","volume":"104","author":"Minniti","year":"2012","journal-title":"Handb. Clin. Neurol."},{"issue":"10","key":"10.1016\/j.tranon.2023.101710_bib0073","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.clon.2018.07.001","article-title":"Science in focus: biological optimisation of radiotherapy fraction size in an era of immune oncology","volume":"30","author":"Wilkins","year":"2018","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0074","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fonc.2016.00165","article-title":"Challenges of using high-dose fractionation radiotherapy in combination therapy","volume":"6","author":"Yang","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2023.101710_bib0075","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920965853","article-title":"Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-stat3\/hif-1 alpha signaling pathway","volume":"12","author":"Tong","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0076","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4143\/crt.2020.1349","article-title":"Re-irradiation with moderate hypo-fractionation using intensity modulated photon or proton radiation therapy in locally recurrent squamous cell carcinoma of nasopharynx","volume":"54","author":"Nam","year":"2022","journal-title":"Cancer Res. Treat."},{"issue":"Supplement","key":"10.1016\/j.tranon.2023.101710_bib0077","article-title":"Comparison of two schedules of hypo-fractionated radiotherapy in locally advanced head-and-neck cancers","volume":"18","author":"Adlakha","year":"2022","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0078","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/ol.2015.3185","article-title":"Clinical research on alternating hyperfraction radiotherapy for massive hepatocellular carcinoma","volume":"10","author":"Long","year":"2015","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.tranon.2023.101710_bib0079","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3857\/roj.2021.00325","article-title":"Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer","volume":"39","author":"Takeda","year":"2021","journal-title":"Radiat. Oncol. J."},{"issue":"12","key":"10.1016\/j.tranon.2023.101710_bib0080","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/jnr.24929","article-title":"Ultra-hyper-fractionated radiotherapy for high-grade gliomas","volume":"99","author":"Frosina","year":"2021","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.tranon.2023.101710_bib0081","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jnr.25030","article-title":"Improving control of high-grade glioma by ultra-hyper-fractionated radiotherapy","volume":"100","author":"Frosina","year":"2022","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.tranon.2023.101710_bib0082","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: an emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2023.101710_bib0083","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030655","article-title":"Assessing the future of solid tumor immunotherapy","volume":"10","author":"Guha","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.tranon.2023.101710_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188434","article-title":"Targeting tumor-associated macrophages for cancer immunotherapy","volume":"1874","author":"Shu","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.tranon.2023.101710_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/resp.13870","article-title":"Radiotherapy treatment for lung cancer: current status and future directions","volume":"25","author":"Vinod","year":"2020","journal-title":"Respirology"},{"issue":"12","key":"10.1016\/j.tranon.2023.101710_bib0086","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s12094-020-02378-8","article-title":"Tumor microenvironment, immune response and post-radiotherapy tumor clearance","volume":"22","author":"Koukourakis","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"602","key":"10.1016\/j.tranon.2023.101710_bib0087","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3631","article-title":"Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade","volume":"13","author":"Patel","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.tranon.2023.101710_bib0088","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.it.2022.01.006","article-title":"Lighting up the tumor fire with low-dose irradiation","volume":"43","author":"Herrera","year":"2022","journal-title":"Trends Immunol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:27:56Z","timestamp":1761845276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523323000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":88,"alternative-id":["S1936523323000967"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101710","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose radiotherapy effects the progression of anti-tumor response","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101710"}}